CHADDS FORD, PA -- (MARKET WIRE) -- January 17, 2007 -- Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), announced that it received a subpoena today from the U.S. Department of Health and Human Services, Office of Inspector General, requesting documents from 1999 to the present regarding the company’s sales and promotional practices relating to Lidoderm® (lidocaine patch 5%). The company intends to cooperate with this request. The subpoena requests documents generally related to the company’s knowledge of the use of Lidoderm® for non-indicated uses by physicians.
